Clinical trial
Use of Risperidone in ECT for Treatment Resistant Depression
NCT00203723 · University of California, Los Angeles, Other · Terminated
Key facts
| NCT number | NCT00203723 |
|---|---|
| Title | Use of Risperidone in ECT for Treatment Resistant Depression |
| Official title | A Comparison Study of Combined ECT and Risperidone Versus ECT Alone for Treatment Resistant Depression. |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | Janssen, LP Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depression |
| Intervention type | Drug |
| Interventions | Risperidone |
| Enrollment | 45 |
| Start date | Mar 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | May 18, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: